CORONARY OSTIAL PERFUSION CANNULA. Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

coronary ostial perfusion cannula.

covidien peru s.a. -

CORONARY ANGIOPLASTY CATHETER, MARCA: RIVER® Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

coronary angioplasty catheter, marca: river®

medical peruvian services eirl -

ALVERIN 18,7 mg/g PASTA ORAL PARA CABALLOS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

alverin 18,7 mg/g pasta oral para caballos

zoetis spain s.l. - ivermectina - pasta oral - ivermectina 18,7 - ivermectina - caballos

EQVALAN DUO PASTA ORAL España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

eqvalan duo pasta oral

boehringer ingelheim animal health espaÑa s.a.u. - ivermectina - pasta oral - ivermectina 1,55 - ivermectina, combinaciones - caballos

EQVALAN PASTA ORAL # EQUALAN PASTA ORAL España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

eqvalan pasta oral # equalan pasta oral

boehringer ingelheim animal health espaÑa s.a.u. - ivermectina - pasta oral - ivermectina 18,7 - ivermectina - caballos

MAXIMEC PASTA ORAL España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

maximec pasta oral

bimeda animal health limited - ivermectina - pasta oral - ivermectina 18,7 - ivermectina - caballos

NEOMECTIN 12 mg/g GEL ORAL PARA CABALLOS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

neomectin 12 mg/g gel oral para caballos

le vet. b.v. - ivermectina - gel oral - ivermectina 12 - ivermectina - caballos

PARVO+CORONA Argentina - español - SANI (Asociación de Cooperativas Argentinas)

parvo+corona

merial - caninos;

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Unión Europea - español - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - besilato de clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - agentes antitrombóticos - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). elevación del segmento st infarto agudo de miocardio, en combinación con aas en los pacientes tratados médicamente elegibles para la terapia trombolítica. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. para más información, por favor refiérase a la sección 5.

FENCOVIS SUSPENSION INYECTABLE España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

fencovis suspension inyectable

boehringer ingelheim vetmedica gmbh - escherichia coli inactivado (adhesina f5), cepa 08:k35 - suspensiÓn inyectable - escherichia coli inactivado (adhesina f5), cepa 08:k35 ≥ 1 - rotavirus bovino + coronavirus bovino + escherichia - vacas gestantes; novillas gestantes